| 摘要 |
The present invention relates to solid pharmaceutical dosage forms comprising the drug substance 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1 -{6-[4-(4-ethyl-piperazin-1 -yl)- phenylamino]-pyrimidin-4-yl}-1 -methyl-urea or any pharmaceutically acceptable salt thereof. It further relates to processes of making said solid pharmaceutical dosage forms. |
